Reduced Parietooccipital White Matter Glutamine Measured by Proton Magnetic Resonance Spectroscopy in Treated Graves’ Disease Patients | Zendy

Else Rubæk Danielsen | Zendy; Tina Vraamark Elberling | Zendy; Å.K. Rasmussen | Zendy; J. Dock | Zendy; Merete Hørding | Zendy; Hans Perrild | Zendy; Gunhild Waldemar | Zendy; Ulla FeldtRasmussen | Zendy; C. Thomsen | Zendy

Open Access

Reduced Parietooccipital White Matter Glutamine Measured by Proton Magnetic Resonance Spectroscopy in Treated Graves’ Disease Patients

Author(s) -

Else Rubæk Danielsen,

Tina Vraamark Elberling,

Å.K. Rasmussen,

J. Dock,

Merete Hørding,

Hans Perrild,

Gunhild Waldemar,

Ulla FeldtRasmussen,

C. Thomsen

Publication year - 2008

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2007-2161

Subject(s) - white matter , glutamine , choline , medicine , graves' disease , gastroenterology , endocrinology , glutamate receptor , thyroid , magnetic resonance imaging , chemistry , radiology , biochemistry , receptor , amino acid

Graves' disease is an autoimmune disease of the thyroid gland. Patients often have affective and cognitive complaints, whether these disappear after treatment remains disputed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research